Table 1 Patients Characteristics
|
DC (n = 67) |
D (n = 65) | ||
|---|---|---|---|
| N (%) | N (%) | P-value | |
| Age | 62 | 63 | |
| Median (min-max) | 39 - 78 | 39 - 83 | |
| Sex | |||
| Male | 64 (95.5) | 56 (86.2) | P = 0.074 |
| Female | 3 (4.5) | 9 (13.8) | |
| Performance status | |||
| 0 | 26 (38.8) | 14 (21.5) | P = 0.088 |
| 1 | 33 (49.3) | 39 (60.0) | |
| 2 | 8 (11.9) | 12 (18.5) | |
| Histological Type | |||
| Squamous | 16 (23.9) | 18 (27.7) |
Adeno Ca vs Non-Adeno Ca P = 0.380 |
| Adeno Ca | 26 (38.8) | 31 (47.7) | |
| Large Cell | 2 (3.0) | 1 (1.5) | |
| Mixed | 1 (1.5) | 1 (1.5) | |
| Other | 22 (32.8) | 14 (21.5) | |
| No. of Organs Involved | |||
| Median (min- max) | 2.00 (1 - 8) | 2.00 (1 - 5) |
1-2 vs > = 3 P = 0.444 |
|
Mann-Whitney U = 2142.500 P = 0.867 | |||
| Prior therapy | |||
| Paclitaxel | 8 (11.9) | 7 (10.8) | P = 0.109 |
| Response to prior therapy |
CR+PR vs SD+PD P = 0.799 | ||
| CR | 1 (1.5) | 1 (1.5) | |
| PR | 7 (10.4) | 8 (12.3) | |
| SD | 18 (26.9) | 19 (29.2) | |
| PD | 41 (61.2) | 37 (56.9) |
